{"lastClose": 4.150000095367432, "len": 1007, "date": "2023-04-03", "alpha_1": -0.8117288119605311, "beta_1": 0.8266715283298359, "drawup_1": 0.7155424508464454, "natr_1": 18.90153110292832, "sup_1": -0.050602455967919326, "res_1": 0.214457775074807, "bullPattern_1": ["BELTHOLD", "LONGLINE", "SEPARATINGLINES"], "bearPattern_1": [], "rsi_1": 43.718592994926716, "adx_1": 33.67888824748018, "drawdown_1": -0.8070175398354672, "stratHoldSharpe_1": -0.8842720688544534, "stratHoldAlpha_1": 250.29315066977202, "stratHoldDrawdown_1": -0.7270152348890703, "alpha_3mo": -0.777220916097055, "beta_3mo": 1.2667464119957594, "drawup_3mo": 0.1273486718940231, "natr_3mo": 18.90153110292832, "sup_3mo": -0.0016064432839746807, "res_3mo": 0.11485940217337406, "bullPattern_3mo": ["3INSIDE"], "bearPattern_3mo": [], "rsi_3mo": 57.05521274974337, "adx_3mo": 17.218870333789877, "drawdown_3mo": -0.31111111797913593, "stratHoldSharpe_3mo": -1.1463246599758292, "stratHoldAlpha_3mo": 250.49435837168753, "stratHoldDrawdown_3mo": -0.2828282888196728, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2019.0, "Name": "NGM Biopharmaceuticals Inc.", "Market Cap": 339163369, "Country": "United States", "Sector": "Health Care", "alpha%_1": 0.005784825197370908, "beta%_1": 0.38248561869002856, "drawup%_1": 0.6764614840873652, "natr%_1": 0.9999999998069807, "drawdown%_1": 0.01311777296143566, "stratHoldSharpe%_1": 0.13472509800872073, "stratHoldAlpha%_1": 0.004725730123389532, "stratHoldDrawdown%_1": 0.01437195508951481, "alpha%_3mo": 0.11886525422166522, "beta%_3mo": 0.664704975348616, "drawup%_3mo": 0.30385743321752773, "natr%_3mo": 0.9999999994784079, "drawdown%_3mo": 0.15545567030226115, "stratHoldSharpe%_3mo": 0.19399560170529379, "stratHoldAlpha%_3mo": 0.15543739021664715, "stratHoldDrawdown%_3mo": 0.1596207772190803}